Literature DB >> 20017800

Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host.

Jennifer L Krauss, Jan Potempa, John D Lambris, George Hajishengallis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20017800      PMCID： PMC2796596          DOI： 10.1111/j.1600-0757.2009.00324.x

Source DB:  PubMed          Journal:  Periodontol 2000        ISSN： 0906-6713            Impact factor:   7.589


× No keyword cloud information.
  179 in total

Review 1.  Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens.

Authors:  Carrie M Rosenberger; B Brett Finlay
Journal:  Nat Rev Mol Cell Biol       Date:  2003-05       Impact factor: 94.444

2.  Regulation by C5a of neutrophil activation during sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Kurt D Bernacki; Jayne S Reuben; Ines J Laudes; Thomas A Neff; Hongwei Gao; Cecilia Speyer; Vidya J Sarma; Firas S Zetoune; Peter A Ward
Journal:  Immunity       Date:  2003-08       Impact factor: 31.745

3.  Role of dentilisin in Treponema denticola epithelial cell layer penetration.

Authors:  Bo Chi; Mingshan Qi; Howard K Kuramitsu
Journal:  Res Microbiol       Date:  2003-11       Impact factor: 3.992

4.  Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications.

Authors:  Fredrik Bäckhed; Staffan Normark; Elke K H Schweda; Stefan Oscarson; Agneta Richter-Dahlfors
Journal:  Microbes Infect       Date:  2003-10       Impact factor: 2.700

5.  Adhesins encoded by the gingipain genes of Porphyromonas gingivalis are responsible for co-aggregation with Prevotella intermedia.

Authors:  Arihide Kamaguchi; Tohru Ohyama; Eiko Sakai; Reiko Nakamura; Toshihiro Watanabe; Hisae Baba; Koji Nakayama
Journal:  Microbiology       Date:  2003-05       Impact factor: 2.777

6.  Mixed infections with Porphyromonas gingivalis and Treponema denticola cause excessive inflammatory responses in a mouse pneumonia model compared with monoinfections.

Authors:  Ryuta Kimizuka; Tetsuo Kato; Kazuyuki Ishihara; Katsuji Okuda
Journal:  Microbes Infect       Date:  2003-12       Impact factor: 2.700

7.  Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at toll-like receptor 4 in human endothelial cells.

Authors:  Stephen R Coats; Robert A Reife; Brian W Bainbridge; T Thu-Thao Pham; Richard P Darveau
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

8.  Chemical structure and immunobiological activity of lipid A from Prevotella intermedia ATCC 25611 lipopolysaccharide.

Authors:  Masahito Hashimoto; Yasuyuki Asai; Riyoko Tamai; Takayoshi Jinno; Katsumi Umatani; Tomohiko Ogawa
Journal:  FEBS Lett       Date:  2003-05-22       Impact factor: 4.124

9.  DNA microarray analysis of human gingival fibroblasts from healthy and inflammatory gingival tissues.

Authors:  Pao-Li Wang; Kiyoshi Ohura; Takeo Fujii; Mari Oido-Mori; Yusuke Kowashi; Masanori Kikuchi; Yasushi Suetsugu; Junzo Tanaka
Journal:  Biochem Biophys Res Commun       Date:  2003-06-13       Impact factor: 3.575

10.  Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.

Authors:  Rish K Pai; Marilyn Convery; Thomas A Hamilton; W Henry Boom; Clifford V Harding
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422
View more
  33 in total

1.  Immune evasion strategies of Porphyromonas gingivalis.

Authors:  George Hajishengallis
Journal:  J Oral Biosci       Date:  2011

Review 2.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

3.  Adsorption of components of the plasma kinin-forming system on the surface of Porphyromonas gingivalis involves gingipains as the major docking platforms.

Authors:  Maria Rapala-Kozik; Grazyna Bras; Barbara Chruscicka; Justyna Karkowska-Kuleta; Aneta Sroka; Heiko Herwald; Ky-Anh Nguyen; Sigrun Eick; Jan Potempa; Andrzej Kozik
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

4.  FACIN, a Double-Edged Sword of the Emerging Periodontal Pathogen Filifactor alocis: A Metabolic Enzyme Moonlighting as a Complement Inhibitor.

Authors:  Monika Jusko; Beata Miedziak; David Ermert; Michal Magda; Ben C King; Ewa Bielecka; Kristian Riesbeck; Sigrun Eick; Jan Potempa; Anna M Blom
Journal:  J Immunol       Date:  2016-09-16       Impact factor: 5.422

Review 5.  Complement and dysbiosis in periodontal disease.

Authors:  George Hajishengallis; John D Lambris
Journal:  Immunobiology       Date:  2012-11       Impact factor: 3.144

6.  Structure of factor H-binding protein B (FhbB) of the periopathogen, Treponema denticola: insights into progression of periodontal disease.

Authors:  Daniel P Miller; Jessica K Bell; John V McDowell; Daniel H Conrad; John W Burgner; Annie Héroux; Richard T Marconi
Journal:  J Biol Chem       Date:  2012-02-24       Impact factor: 5.157

7.  Oral microbial biofilm stimulation of epithelial cell responses.

Authors:  Rebecca Peyyala; Sreenatha S Kirakodu; Karen F Novak; Jeffrey L Ebersole
Journal:  Cytokine       Date:  2012-01-21       Impact factor: 3.861

Review 8.  Polymicrobial synergy and dysbiosis in inflammatory disease.

Authors:  Richard J Lamont; George Hajishengallis
Journal:  Trends Mol Med       Date:  2014-11-20       Impact factor: 11.951

9.  Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis.

Authors:  Tomoki Maekawa; Toshiharu Abe; Evlambia Hajishengallis; Kavita B Hosur; Robert A DeAngelis; Daniel Ricklin; John D Lambris; George Hajishengallis
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

10.  Inhibition of GSK3 abolishes bacterial-induced periodontal bone loss in mice.

Authors:  Karina Adamowicz; Huizhi Wang; Ravi Jotwani; Iris Zeller; Jan Potempa; David A Scott
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.